| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |